However, when the same data were analysed using a Cox-regression model, a borderline significant association between CA 19-9 response and survival was noted ( Hess et al , 2008 ).
← all excerpts
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone.
1
—
—